Erythropoietin receptors are expressed in the central nervous system of mid-trimester human fetuses

Pediatric Research

Volumn 40, Issue 3, 1996, Pages 376-380

  Li, Yan ^a   Juul, Sandra E ^a   Morris Wiman, Joyce A ^b   Calhoun, Darlene A ^a   Christensen, Robert D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; EPENDYMA CELL; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 0029830092     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199609000-00002     Document Type: Article

References (36)

1. Maier RF, Oblanden M, Scigalla P, Linderkamp O, Due G, Hieronimi G, Halliday HL, Versmold HT, Moriette G, Jorch G 1994 The effect of epoietin-β (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 330:1173-1178
2. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF 1994 Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 93:918-923
3. Ohls RK, Hunter DD, Christensen RD 1993 A randomized, placcbo-controlled trial of recombinant erythropoietin as treatment for the anemia of bronchopulmonary dysplasia. J Pediatr 123:996-1000
4. Ohls RK 1995 Recombinant human erythropoietin to prevent and treat the anemia of prematurity. Erythropoiesis 6:35-45
5. Shannon KM, Keith III JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, Gleason CA, Bifano EM, Millard DD, Davis CB, Stevenson DK, Alverson DC, Simmons CF, Brim M, Abels RI, Phibbs RH 1995 Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95:1-8
6. Christensen RD 1989 Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity." Pediatrics 83:793-796
7. Shireman TI, Hilsenrath PE, Strauss RG, Widness JA, Mutnick AH 1994 Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis. Arch Pediatr Adolesc Med 148:582-588
8. Fain J, Hilsenrath JA, Widness RG, Strauss RG, Mutnick AH 1995 A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity. Transfusion 35:936-943
9. Hoffman HJ, Damus K, Hillman L, Krongrad E 1988 Risk factors for SIDS: results of the National Institiute of Child Health and Human Development SIDS cooperative epidemiological study. Ann NY Acad Sci 533:13-30
10. Hoffman HJ, Hillman LS 1992 Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol 19:717-737
11. Emmerson AJB, Coles HJ, Stern CMM, Pearson TC 1993 Double blind trial of recombinant erythropoietin in preterm infants. Arch Dis Child 68:291-296
12. Mufson RA, Gesner TG 1987 Binding and internalization of recombinant human erythropoielin in murine erythroid precursor cells. Blood 69:1485-1490
13. Migliaccio AR, Migliaccio G, D'Andrea A, Baiocchi M, Crotta S, Nicolis S, Ottolenghi S, Adamson JW 1991 Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface. Proc Natl Acad Sci USA 88:11086-11090
14. Sawyer ST, Krantz SB, Luna J 1987 Identification of the receptor for erythropoietin by cross-linking to Friend virus- infected erythroid cells. Proc Natl Acad Sci USA 84:3690-3694
15. Sawyer ST, Krantz SB, Sawada K 1989 Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood 74:103-109
16. Fraser JK, Lin FK, Berridge MV 1988 Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562. Blood 71:104-109
17. Hoshino S, Teramura M, Takahashi M, Motoji T, Oshimi K, Ueda M, Mizoguchi H 1989 Expression and characterization of erythropoietin receptors on normal human bone marrow cells, Int J Cell Cloning 7:156-167
18. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M 1990 Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978-5982
19. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT 1994 Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978
20. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas FJ, Tabira T, Sasaki R 1993 Functional erythropoietin receptor of the cells with neural characteristics. J Biol Chem 268:11208-11216
21. Liu Z-Y, Chin K, Noguchi C 1994 Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 166:159-169
22. Yasuda Y, Nagao M, Okano M, Masuda S, Sasaki R, Konishi H, Tanimura T 1993 Localization of erythropoietin and erythropoietin-receptor in postimplantation mouse embryos. Dev Growth Differ 35:711-722
23. Juul SE, Harcum J, Li Y, Christensen RD 1996 Erythropoietin is present in the cerebrospinal fluid of neonates. Pediatr Res 39:288A(abstr)
24. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R 1994 A novel site of erythropoietin production. J Biol Chem 269:19488-19493
25. Tan CC, Eckardt K-U, Firth JD, Ratcliffe PJ 1992 Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 263:F474-F481
26. Bikfalvi A, Han ZC 1994 Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia 8:523-529
27. Konishi Y, Chui D-H, Hirose H, Kunishita T, Tabira T 1993 Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609:29-35
28. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
29. Winkelmann JC, Penny LA, Deaven LL, Forget BG, Jenkins RB 1990 The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p. Blood 76:24-30
30. Wilson JT, Wlison LB, Reddy VB 1988 Nucleotide sequence of the coding portion of human alpha globin messenger RNA. J Biol Chem 255:2807-2815
31. Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T 1985 Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82:6133-6137
32. Behrman RE, Shiono PH 1992 Neonatal risk factors. In: Fanaroff AA, Martin RJ (eds) Neonatal-Perinatal Medicine-Diseases of the Fetus and Infant. Mosby, St. Louis
33. Strauss RG 1995 Red blood cell transfusion practices in the neonate. Clin Perinatol 22:641-655
34. Ohls RK, Osborne KA, Christensen RD 1995 Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo controlled trial. J Pediatr 126:421
35. Dallman PR (ed) 1993 Anemia of prematurity: the prospects for avoiding blood transfusion by treatment with recombinant human erythropoietin. In: Advances in Pediatrics. Mosby, St. Louis
36. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M 1993 Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43:1010-1014